Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
29
Number of overlapping holdings
45.3%
% of CNCR's 64 holdings also in BBC
27.9%
% of BBC's 125 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus BBC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in BBC |
Overlap | |
|---|---|---|---|---|
 |
MERUS N.V. | 1.6% | 1.1% | 1.1% |
 |
ALLOGENE THERAPEUTICS, INC. | 1.4% | 1.1% | 1.1% |
|
SYNDAX PHARMACEUTICALS INC | 1.6% | 1.0% | 1.0% |
|
SUMMIT THERAPEUTICS INC | 2.2% | 1.0% | 1.0% |
|
RECURSION PHARMACEUTICALS, INC CLASS A | 1.4% | 0.9% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to BBC
|
FATE THERAPEUTICS INC | 2.1% |
|
SCHRODINGER, INC. | 2.0% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 1.8% |
|
2SEVENTY BIO, INC. | 1.8% |
|
Y-MABS THERAPEUTICS, INC. | 1.8% |
 |
BIONTECH SE SPONSORED ADR | 1.8% |
|
EXELIXIS INC | 1.8% |
 |
GENMAB A/S SPONSORED ADR | 1.7% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | 1.7% |
|
BLUEPRINT MEDICINES CORP. | 1.7% |
CNCR Underweight Relative to BBC
|
AKERO THERAPEUTICS, INC. | -1.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | -1.4% |
|
SANA BIOTECHNOLOGY, INC. | -1.3% |
|
XERIS PHARMACEUTICALS INC | -1.3% |
|
ARCUTIS BIOTHERAPEUTICS INC | -1.2% |
 |
PROTHENA CORP PLC | -1.1% |
|
ANAPTYSBIO, INC. | -1.1% |
|
VERVE THERAPEUTICS, INC. | -1.1% |
|
VIR BIOTECHNOLOGY, INC. | -1.1% |
|
DIANTHUS THERAPEUTICS INC | -1.0% |